This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Petersen, P. Articles by Godtfredsen, J. Search for Related Content PubMed PubMed Citation Articles by Petersen, P. Articles by Godtfredsen, J.

Stroke, Vol 17, 622-626, Copyright © 1986 by American Heart Association

ARTICLES

Embolic complications in paroxysmal atrial fibrillation

P Petersen and J Godtfredsen

The incidence of embolic complications among 426 patients with initial paroxysmal atrial fibrillation (PAF) was analysed. A distinct clustering of emboli was seen at the time of onset of PAF. After transition to chronic atrial fibrillation (CAF), which developed in 141 patients (33.1%), the incidence of emboli was seen to rise to a new level several times higher than the incidence level for patients with PAF. Also in this group a distinct clustering of emboli was seen during the first year after transition to CAF. On this background it is suggested that patients with PAF may benefit from treatment with anti- arrhythmic agents in order to prevent the development of CAF and that anticoagulants for stroke prevention seems especially desirable in atrial fibrillation (AF) of recent onset.

This article has been cited by other articles:

				R. Nieuwlaat, T. Dinh, S. B. Olsson, A. J. Camm, A. Capucci, R. G. Tieleman, G. Y.H. Lip, H. J.G.M. Crijns, and on behalf of the Euro Heart Survey Investigators Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur. Heart J., April 1, 2008; 29(7): 915 - 922. [Abstract] [Full Text] [PDF]

				C. S. van der Hooft, J. Heeringa, G. G. Brusselle, A. Hofman, J. C. M. Witteman, J. H. Kingma, M. C. J. M. Sturkenboom, and B. H. Ch. Stricker Corticosteroids and the risk of atrial fibrillation. Arch Intern Med, May 8, 2006; 166(9): 1016 - 1020. [Abstract] [Full Text] [PDF]

				R. Mehra, E. J. Benjamin, E. Shahar, D. J. Gottlieb, R. Nawabit, H. L. Kirchner, J. Sahadevan, and S. Redline Association of Nocturnal Arrhythmias with Sleep-disordered Breathing: The Sleep Heart Health Study Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 910 - 916. [Abstract] [Full Text] [PDF]

				A. Capucci, M. Santini, L. Padeletti, M. Gulizia, G. Botto, G. Boriani, R. Ricci, S. Favale, F. Zolezzi, N. Di Belardino, et al. Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1913 - 1920. [Abstract] [Full Text] [PDF]

				C. S. van der Hooft, J. Heeringa, G. van Herpen, J. A. Kors, J. H. Kingma, and B. H. Ch. Stricker Drug-induced atrial fibrillation J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2117 - 2124. [Abstract] [Full Text] [PDF]

				E. Manasse, P.G. Colombo, A. Barbone, P. Braidotti, G. Bulfamante, M. Roincalli, and R. Gallotti Clinical histopathology and ultrastructural analysis of myocardium following microwave energy ablation Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 573 - 577. [Abstract] [Full Text] [PDF]

				G.Y.H. Lip and F.L. L. S. Hee Paroxysmal atrial fibrillation QJM, December 1, 2001; 94(12): 665 - 678. [Abstract] [Full Text] [PDF]

				R. G. Hart, L. A. Pearce, R. M. Rothbart, J. H. McAnulty, R. W. Asinger, J. L. Halperin, and for the Stroke Prevention in Atrial Fibrillation I Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy J. Am. Coll. Cardiol., January 1, 2000; 35(1): 183 - 187. [Abstract] [Full Text] [PDF]

				G. Corrado, M. Santarone, S. Beretta, G. Tadeo, L.M. Tagliagambe, G. Foglia-Manzillo, M. Spata, E. Miglierina, F. Acquati, and M. Santarone Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: A single centre 8{middle dot}5-year experience Europace, January 1, 2000; 2(2): 119 - 126. [Abstract] [PDF]

				M Gasparini, M Mantica, M Brignole, L Gianfranchi, C Menozzi, F Pizzetti, G Magenta, P Delise, A Proclemer, S Tognarin, et al. Thromboembolism after atrioventricular node ablation and pacing: long term follow up Heart, October 1, 1999; 82(4): 494 - 498. [Abstract] [Full Text] [PDF]

				S. Levy, M. Maarek, P. Coumel, L. Guize, J. Lekieffre, J.-L. Medvedowsky, and A. Sebaoun Characterization of Different Subsets of Atrial Fibrillation in General Practice in France : The ALFA Study Circulation, June 15, 1999; 99(23): 3028 - 3035. [Abstract] [Full Text] [PDF]

				M. H. Eckman, R. H. Falk, and S. G. Pauker Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation Arch Intern Med, August 10, 1998; 158(15): 1669 - 1677. [Abstract] [Full Text]

				H.-J. Lin, P. A. Wolf, E. J. Benjamin, A. J. Belanger, and R. B. D'Agostino Newly Diagnosed Atrial Fibrillation and Acute Stroke : The Framingham Study Stroke, September 1, 1995; 26(9): 1527 - 1530. [Abstract] [Full Text]

				W. J. Manning, D. I. Silverman, S. Gordon, H. M. Krumholz, and P. S. Douglas Cardioversion from Atrial Fibrillation without Prolonged Anticoagulation with Use of Transesophageal Echocardiography to Exclude the Presence of Atrial Thrombi N. Engl. J. Med., March 18, 1993; 328(11): 750 - 755. [Abstract] [Full Text]

				J. L Halperin Prevention of embolism in atrial fibrillation Vascular Medicine, September 1, 1991; 2(2): 111 - 119. [PDF]